Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccination to prevent type 1 diabetes.

Matthias G von Herrath1

  • 1La Jolla Institute for Allergy and Immunology, Division of Immune Regulation, San Diego, CA 92121, USA. matthias@liai.org

Expert Review of Vaccines
|August 12, 2003
PubMed
Summary

Novel immune therapies for autoimmune disorders are emerging, moving from systemic immune modulators to antigen-specific treatments. Careful individual monitoring and strategic dosing are crucial for these advanced interventions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liraglutide protects β-cells in novel human islet spheroid models of type 1 diabetes.

Clinical immunology (Orlando, Fla.)·2022
Same author

Peripheral autoreactive CD8 T-cell frequencies are too variable to be a reliable predictor of disease progression of human type 1 diabetes.

Clinical & translational immunology·2021
Same author

Means, Motive, and Opportunity: Do Non-Islet-Reactive Infiltrating T Cells Contribute to Autoimmunity in Type 1 Diabetes?

Frontiers in immunology·2021
Same author

HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes.

Journal of autoimmunity·2021
Same author

New Insights Into the Role of Autoreactive CD8 T Cells and Cytokines in Human Type 1 Diabetes.

Frontiers in endocrinology·2021
Same author

Corona Pandemic: Assisted Isolation and Care to Protect Vulnerable Populations May Allow Us to Shorten the Universal Lock-Down and Gradually Re-open Society.

Frontiers in public health·2020

Area of Science:

  • Immunology
  • Autoimmune Diseases
  • Therapeutic Development

Background:

  • Current immune-based interventions for autoimmune disorders include systemic immune modulators like cytokine antibodies.
  • These systemic approaches are either in clinical trials or already in use.
  • The next generation of therapies aims for antigen-specific immune modulation.

Purpose of the Study:

  • To discuss current and next-generation immune-based interventions for autoimmune disorders.
  • To highlight the challenges in designing antigen-specific therapies.
  • To suggest combinatorial approaches for enhanced treatment efficacy.

Main Methods:

  • Review of existing systemic immune modulators.
  • Discussion of antigen-specific immune strategies.
  • Exploration of combinatorial therapeutic approaches.

Main Results:

  • Systemic immune modulators are established therapeutic options.
  • Antigen-specific interventions represent a more complex but promising future direction.
  • Individualized monitoring and precise administration are key for novel strategies.

Conclusions:

  • Immune-based therapies offer novel treatment avenues for autoimmune diseases.
  • Antigen-specific strategies require careful design and personalized application.
  • Combinatorial approaches may optimize the effectiveness of these advanced immune interventions.

Related Experiment Videos